How to prevent the next Marathon Pharmaceuticals [version 1; referees: 2 approved, 1 approved with reservations]
In recent years, several drug companies have exploited U.S. regulatory policies to acquire exclusive rights to cheap therapies and substantially raise their prices, and Federal agencies and state governments are exploring various ways to prevent or punish such behavior in the future. Among these cas...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
F1000 Research Ltd
2018-01-01
|
| Series: | F1000Research |
| Online Access: | https://f1000research.com/articles/7-74/v1 |